Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a global leader in medical technology that advances the world of health by improving medical discovery, diagnostics, and the delivery of care. Founded in 1897, BD has a rich history of innovation and commitment to enhancing patient outcomes through its diverse range of products and services.

With a presence in over 190 countries, BD operates in three primary segments: BD Medical, BD Diagnostics, and BD Biosciences. Each segment focuses on different aspects of healthcare, from medication management and surgical instruments to diagnostic systems and research tools.

• BD Medical: This segment provides a wide array of medical devices, including syringes, needles, and infusion systems, aimed at improving patient safety and healthcare efficiency.
• BD Diagnostics: BD Diagnostics offers innovative solutions for disease detection and monitoring, including microbiology and molecular diagnostics.
• BD Biosciences: This division specializes in research and clinical applications, providing tools for cell analysis and flow cytometry.

BD is committed to sustainability and corporate responsibility, focusing on reducing its environmental impact and enhancing access to healthcare globally. The company invests significantly in research and development to drive innovation and meet the evolving needs of healthcare professionals and patients alike.

Through its dedication to quality and excellence, Becton, Dickinson and Company continues to be at the forefront of medical technology, striving to improve health outcomes and enhance the quality of life for people around the world.